Environmental risk factors in multiple sclerosis

References

• Armstrong BK, White E, Saracci R. Principles of Exposure Measurement in Epidemiology. Oxford University Press, NY, USA (1994).
   Google Scholar
• MacMahon B, Trichopoulos D. Epidemiology: Principles and Methods. Lippincott Williams and Wilkins, PA, USA (1996).
   Google Scholar
• Kleinbaum DG, Kupper LL. Epidemiologic Research. Van Nostrand Reinhold, NY, USA (1982).
   Google Scholar
• Kelsey JL, Thompson WD, Evans AS. Methods in Observational Epidemiology. Oxford University Press, NY, USA (1986).
   Google Scholar
• Hennekens CH, Buring JE, Mayrent SC. Epidemiology in Medicine. Little, Brown and Co., MA, USA (1987).
   Google Scholar
• Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Lippincott Williams and Wilkins, PA, USA (2008).
   Google Scholar
• Rothman KJ. Epidemiology. An Introduction. Oxford University Press, Oxford, UK (2002).
   Google Scholar
• Morgenstern H. Ecological studies. In: Modern Epidemiology. Rothman KJ, Greenland S (Eds). Lippincott Williams and Wilkins, PA, USA, 459–480 (1998).
   Google Scholar
• Feinstein AR. Clinical Epidemiology. The Architecture of Clinical Research. WB Sauders, PA, USA (1985).
   Google Scholar
• Pearce N. Traditional epidemiology, modern epidemiology, and public health. Am. J. Publ. Health86, 678–683 (1996).
   PubMed Web of Science ®Google Scholar
• Lauer K. [The epidemiology of multiple sclerosis]. In: [The inflammatory diseases of the central nervous system]. 3rd Supplementation, 2/97. Henkes HG, Koelmel HW (Eds). EcoMed, Germany 1–86 (1997).
   Google Scholar
• Kantarci OH. Genetics and natural history of multiple sclerosis. Semin. Neurol.28, 7–16 (2008).
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Dyment DA, Ebers GC. Genetic epidemiology: the use of old and new tools for multiple sclerosis. Trends Neurosci.31, 645–652 (2008).
   PubMed Web of Science ®Google Scholar
• Oksenberg JR, Hauser SL. Genetics of multiple sclerosis. In: Multiple Sclerosis: a Comprehensive Text. Raine CS, McFarland HF, Hohlfeld R (Eds). Saunders, Edinburgh, UK, 214–225 (2008).
   Google Scholar
• Kuusisto H, Kaprio J, Kinnunen E, Luukkaala T, Koskenvuo M, Elovaara I. Concordance and heretability of multiple sclerosis in Finland: study on a nationwide series of twins. Eur. J. Neurol.15, 1106–1110 (2008).
   PubMed Web of Science ®Google Scholar
• The International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med.357, 851–862 (2007).
   PubMed Web of Science ®Google Scholar
• Lundmark F, Duvegelt K, Iacobaeus E et al. Variation in interleukin 7 receptor a chain (IL7R) influences risk of multiple sclerosis. Nat. Genet.39, 1108–1113 (2007).
   PubMed Web of Science ®Google Scholar
• Murrell TG, Harbige LS, Robinson IC. A review of the aetiology of multiple sclerosis: an ecological approach. Ann. Hum. Biol.18, 95–112 (1991).
   PubMed Web of Science ®Google Scholar
• Granieri E. Exogenous factors in the aetiology of multiple sclerosis. J. Neurovirol.6(Suppl. 2), 141–146 (2000).
   Google Scholar
• Coo H, Aronson KJ. A systematic review of several potential non-genetic risk factors for multiple sclerosis. Neuroepidemiology23, 1–12 (2004).
   PubMed Web of Science ®Google Scholar
• Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol.3, 709–718 (2004).
   PubMed Web of Science ®Google Scholar
• Kantarci O, Wingerchuk D. Epidemiology and natural history of multiple sclerosis.: new insights. Curr. Opin. Neurol.19, 248–254 (2006).
   PubMed Web of Science ®Google Scholar
• Giovannoni G, Ebers GC. Multiple sclerosis: the environment and causation. Curr. Opin. Neurol.20, 261–268 (2007).
   PubMed Web of Science ®Google Scholar
• Pugliatti M, Harbo HF, Holmøy T et al. Environmental risk factors in multiple sclerosis. Acta Neurol. Scand. Suppl.188, 34–40 (2008).
   PubMedGoogle Scholar
• Pugliatti M, Rosati G. Epidemiology of multiple sclerosis. In: Multiple Sclerosis: a Comprehensive Text. Raine CS, McFarland HF, Hohlfeld R (Eds). Saunders, Edinburgh, UK, 121–140 (2008).
   Google Scholar
• Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol.61, 288–299 (2007).
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: non-infectious factors. Ann. Neurol.61, 504–513 (2007).
   PubMed Web of Science ®Google Scholar
• Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology1, 43–46 (1990).
   PubMedGoogle Scholar
• Savitz DA, Olshan AF. Multiple comparisons and related issues in the interpretation of epidemiological data. Am. J. Epidemiol.142, 904–908 (1995).
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger K. Epidemiology of multiple sclerosis: from risk factors to prevention. Sem. Neurol.28, 17–28 (2008).
   PubMed Web of Science ®Google Scholar
• Fleming JO, Cook TD. Multiple sclerosis and the hygiene hypothesis. Neurology67, 2085–2086 (2006).
   PubMed Web of Science ®Google Scholar
• Sotgiu S, Angius A, Embry A, Rosati G, Musumeci S. Hygiene hypothesis: innate immunity, malaria and multiple sclerosis. Med. Hypotheses70, 819–825 (2008).
   PubMed Web of Science ®Google Scholar
• Nielsen NM, Wohlfahrt J, Melbye M et al. Multiple sclerosis and poliomyelitis. A Danish historical cohort study. Acta Neurol. Scand.101, 384–387 (2000).
   PubMed Web of Science ®Google Scholar
• Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M. Epidemiological study of multiple sclerosis in Israel. Part II. Multiple sclerosis and level of sanitation. J. Neurol. Neurosurg. Psychiatry29, 60–68 (1966).
   PubMed Web of Science ®Google Scholar
• Beebe GW, Kurtzke JF, Kurland LT, Auth TL, Nagler B. Studies on the natural history of multiple sclerosis. 3.Epidemiologic analysis of the army experience in World War II. Neurology17, 1–17 (1967).
   PubMed Web of Science ®Google Scholar
• Russell WR. Multiple sclerosis: occupation and social group at onset. Lancet2, 832–834 (1971).
   PubMed Web of Science ®Google Scholar
• Hammond SR, Mc Leod JG, Macaskill P, English DR. Multiple sclerosis in Australia: socioeconomic factors. J. Neurol. Neurosurg. Psychiatry61, 311–313 (1996).
   PubMed Web of Science ®Google Scholar
• Correale J, Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol.61, 97–108 (2007).
   PubMed Web of Science ®Google Scholar
• Alter M, Xin ZZ, Davanipour Z, Sobel E, Min Lai S, LaRue L. Does delay in acquiring childhood infection increase risk of multiple sclerosis? Ital. J. Neurol. Sci.8, 73–74 (1987).
   PubMedGoogle Scholar
• Niederman JC, Evans AS. Epstein–Barr virus. In: Viral Infections of Humans: Epidemiology and Control. Evans AS, Kaslow RA (Eds). Plenum Medical Book Company, NY, USA, 253–283 (1997).
   Google Scholar
• Lindberg C, Andersen O, Vahlne A, Dalton M, Runmarker B. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology10, 62–65 (1991).
   PubMed Web of Science ®Google Scholar
• Haahr S, Koch-Henriksen N, Möller-Larsen A, Eriksen LS, Andersen HMK. Increased risk of multiple sclerosis after late Epstein –Barr virus infection: a historical prospective study. Mult. Scler.1, 73–77 (1995).
   PubMedGoogle Scholar
• Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Multiple sclerosis after infectious mononucleaosis: record linkage study. J. Epidemiol. Community Health58, 1032–1035 (2004).
   PubMed Web of Science ®Google Scholar
• Pejme J. Infectious mononucleosis. A clinical and haematological study of patients and contacts, and a comparison with healthy subjects. Acta Med. Scand.175(Suppl. 413), 1–83 (1964).
   PubMedGoogle Scholar
• Portegies P, Corssmit N. Epstein–Barr virus and the nervous system. Curr. Opin. Neurol.13, 301–304 (2000).
   PubMed Web of Science ®Google Scholar
• Granieri E, Casetta I. Common childhood and adolescent infections and multiple sclerosis. Neurology49(Suppl. 2), S42–S54 (1997).
   PubMed Web of Science ®Google Scholar
• Levin LI Munger KL, Rubertone MV et al. Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms of multiple sclerosis. JAMA293, 2496–2500 (2005).
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger KL, Lennette ET et al. Epstein–Barr virus antibodies and risk of multiple sclerosis. JAMA286, 3083–3088 (2001).
   PubMed Web of Science ®Google Scholar
• DeLorenze GN, Munger KL, Lennette E et al. Epstein–Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch. Neurol.63, 839–844 (2006).
   PubMedGoogle Scholar
• Sundström P, Juto P, Wadell G et al. An altered immune response to Epstein–Barr virus in multiple sclerosis. A prospective study. Neurology62, 2277–2282 (2004).
   PubMed Web of Science ®Google Scholar
• Luenemann JD, Edwards N, Muraro PA et al. Increased frequency and broadened specificity of latent EBV nuclear antigen-I-specific T cells in multiple sclerosis. Brain129, 1493–1506 (2006).
   PubMed Web of Science ®Google Scholar
• Luenemann JD, Jelcic I, Roberts S et al. EBNA1-specific T cells from patients with multiplesclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2. J. Exp. Med.205, 1763–1773 (2008).
   PubMed Web of Science ®Google Scholar
• Cepok S, Zhou D, Srivastava R et al. Identification of Epstein–Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest.115, 1352–1360 (2005).
   PubMed Web of Science ®Google Scholar
• Rumpold H, Rhodes GH, Bloch PL, Carson DA, Vaughan JH. The glycine–alanine repeating region is the major epitope of the Epstein–Barr nuclear antigen-1 (EBNA-1). J. Immunol.138, 593–599 (1987).
   PubMed Web of Science ®Google Scholar
• Dromey JA, Weenink SM, Peters GH et al. Mapping of epitopes for autoantibodies to the type-1 diabetes autoantigen IA-2 by peptide phage display and molecular modeling: overlap of antibody and T cell determinants. J. Immunol.172, 4084–4090 (2004).
   PubMed Web of Science ®Google Scholar
• Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B. Epstein–Barr virus in pediatric multiple sclerosis JAMA291, 1875–1879 (2004).
   PubMed Web of Science ®Google Scholar
• Pohl D, Krone B, Rostasy K et al. High seroprevalence of Epstein–Barr virus in children with multiple sclerosis. Neurology67, 2063–2065 (2006).
   PubMed Web of Science ®Google Scholar
• Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, Shoenfeld Y. Epstein–Barr virus and cytomegalovirus in autoimmune diseases. Ann. NY Acad. Sci.1108, 567–577 (2007).
   PubMed Web of Science ®Google Scholar
• Lang HL, Jacobsen H, Ikemizu S et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol.3, 940–943 (2002).
   PubMed Web of Science ®Google Scholar
• Serafini B, Rosicarelli B, Franciotta D et al. Dysregulated Epstein–Barr virus infection in the multiple sclerosis brain. J. Exp. Med.204, 2899–2912 (2007).
   PubMed Web of Science ®Google Scholar
• Maggiore G, Trillo-Pazos G, Reynolds R, Giovannoni D, Miller D. Detection of EBV antigens in germinal centres in the brain of people with multiple sclerosis. J. Neurol.255(Suppl. 2), 9 (2008).
   Google Scholar
• Morré SA, van Beek J, De Groot CJ et al. Is Epstein–Barr virus present in the CNS of patients with MS? Neurology56, 692 (2001).
   PubMed Web of Science ®Google Scholar
• Sanders VJ, Felison S, Waddell A, Tourtellotte WW. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J. Neurovirol.2, 249–258 (1996).
   PubMed Web of Science ®Google Scholar
• Opsahl ML, Kennedy PGE. An attempt to investigate the presence of Epstein–Barr virus in multiple sclerosis and normal control brain tissue. J. Neurol.254, 425–430 (2007).
   PubMed Web of Science ®Google Scholar
• Dean G, Kurtzke JF. On the risk of multiple sclerosis according to age at immigration to South Africa. Br. Med. J.3, 725–729 (1971).
   PubMed Web of Science ®Google Scholar
• Kurtzke JF, Heltberg A. Multiple sclerosis in the Faroe Islands: an epitome. J. Clin. Epidemiol.54, 1–22 (2001).
   PubMed Web of Science ®Google Scholar
• Pender MP. Preventing and curing multiple sclerosis by controlling Epstein–Barr virus infection. Autoimmun. Rev.8, 563–568 (2009).
   PubMed Web of Science ®Google Scholar
• Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann. Neurol.59, 499–503 (2006).
   PubMed Web of Science ®Google Scholar
• Challoner PB, Smith KT, Parker JD et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl Acad. Sci. USA92, 7440–7444 (1995).
   PubMed Web of Science ®Google Scholar
• Enbom M. Human herpesvirus 6 in the pathogenesis of multiple sclerosis. APMIS109, 401–411 (2001).
   PubMed Web of Science ®Google Scholar
• Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann. Neurol.53, 189–197 (2003).
   PubMed Web of Science ®Google Scholar
• Clark D. Human herpesvirus type 6 and multiple sclerosis. Herpes11(Suppl. 2), 112A–119A (2004).
   Google Scholar
• Álvarez-Lafuente R, García-Montojo M, de las Heras V et al. Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult. Scler.14, 595–601 (2008).
   PubMed Web of Science ®Google Scholar
• Sundström P, Juto P, Wadell G et al. An altered immune response to Epstein–Barr virus in multiple sclerosis. A prospective study. Neurology62, 2277–2281 (2004).
   PubMed Web of Science ®Google Scholar
• Lycke J, Svennerholm B, Hjelmquist E et al. Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized placebo-controlled, double-blind study. J. Neurol.243, 214–224 (1996).
   PubMed Web of Science ®Google Scholar
• Bech E, Lycke J, Gadeberg P et al. A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology58, 31–36 (2002).
   PubMed Web of Science ®Google Scholar
• Tanaka R, Iwasaki Y, Koprowski H. Intracisternal virus-like particles in brain of a multiple sclerosis patient. J. Neurol. Sci.28, 121–126 (1976).
   PubMed Web of Science ®Google Scholar
• Burks JS, DeVald BL, Jankovsky LD, Gerdes JC. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science209, 933–934 (1980).
   PubMed Web of Science ®Google Scholar
• Salmi A, Ziola B, Hovi T, Reunanen M. Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology32, 292–295 (1982).
   PubMed Web of Science ®Google Scholar
• Murray RS, Brown B, Brian D, Cabirac GF. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann. Neurol.31, 525–533 (1992).
   PubMed Web of Science ®Google Scholar
• Stewart JN, Mounir S, Talbot PJ. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology191, 502–505 (1992).
   PubMed Web of Science ®Google Scholar
• Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. J. Virol.74, 8913–8921 (2000).
   PubMed Web of Science ®Google Scholar
• Dessau RB, Frederiksen JL. Coronaviruses in brain tissue from patients with multiple sclerosis. Eur. J. Neurol.7(Suppl. 3), 94 (2000).
   Google Scholar
• Talbot PJ, Paquette JS, Ciurli C, Antel J, Quellet F. Myelin basic protein and human coronavirus 229E cross-reactive T cells in multipler sclerosis. Ann. Neurol.39, 233–240 (1996).
   PubMed Web of Science ®Google Scholar
• Boucher A, Desforges M, Duquette P, Talbot PJ. Long-term human coronavirus-myelin cross-reactive T cell clones derived from multiple sclerosis patients. Clin. Immunol.123, 258–267 (2007).
   PubMed Web of Science ®Google Scholar
• Jouvenne P, Mounir S, Stewart JN, Richardson CD, Talbot PJ. Sequence analysis of human coronavirus 229E mRNAs 4 and 5: evidence for polymorphism and homology with myelin basic protein. Virus Res.22, 125–141 (1992).
   PubMed Web of Science ®Google Scholar
• Cristallo A, Gambaro F, Ferrante P, Battaglia M, Sereda PM. Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients. New Microbiol.20, 105–114 (1997).
   PubMed Web of Science ®Google Scholar
• Edwards JA, Denis F, Talbot PJ. Activation of glial cells by human coronavirus OC43 infection. J. Neuroimmunol.108, 73–81 (2000).
   PubMed Web of Science ®Google Scholar
• Dolei A, Perron H. The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease. J. Neurovirol.15, 4–13 (2009).
   PubMed Web of Science ®Google Scholar
• Christensen T, Jensen AW, Munch M et al. Characterization of retrovirus from patients with multiple sclerosis. Acta Neurol. Scand. Suppl.169, 49–58 (1997).
   PubMedGoogle Scholar
• Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev. Med. Virol.15, 179–211 (2005).
   PubMed Web of Science ®Google Scholar
• Oleszak EL, Chang JR, Friedman H, Katsetos CD, Platsoucas CD. Theiler’s virus infection: a model for multiple sclerosis. Clin. Microbiol. Rev.17, 174–207 (2004).
   PubMed Web of Science ®Google Scholar
• Chiu CY, Greninger AL, Kanada K et al. Identification of cardioviruses related to Theiler’s murine encephalomyelitis virus in human infections. Proc. Natl Acad. Sci. USA105, 14124–14129 (2008).
   PubMed Web of Science ®Google Scholar
• Blinkova O, Kapoor A, Victoria J et al. Cardioviruses are genetically diverse and cause common enteric infections in south Asian children. J. Virol.83, 4631–4641 (2009).
   PubMed Web of Science ®Google Scholar
• Ross RT, Cheang M. Geographic similarities between varicella and multiple sclerosis: an hypothesis on the environmental factor of multiple sclerosis. J. Clin. Epidemiol.48, 731–732 (1995).
   PubMed Web of Science ®Google Scholar
• Ross RT, Nicolle LE, Cheang M. Varicella zoster virus and multiple sclerosis in a Hutterite population. J. Clin. Epidemiol.48, 1319–1324 (1995).
   PubMed Web of Science ®Google Scholar
• Compston DA, Vakarelis BN, Paul E, McDonald WI, Batchelor JR, Muns CA. Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain109, 325–344 (1986).
   PubMed Web of Science ®Google Scholar
• Sullivan CB, Visscher BR, Detels R. Multiple sclerosis and age at exposure to childhood diseases and animals: cases and their friends. Neurology34, 1144–1148 (1984).
   PubMed Web of Science ®Google Scholar
• Rodríguez-Violante M, Ordoñez G, Ramirez Bermudez J, Sotelo J, Corona T. Association of a history of varicella virus infection with multiple sclerosis. Clin. Neurol. Neurosurg.111, 54–56 (2009).
   PubMed Web of Science ®Google Scholar
• Mikaeloff Y, Cariade G, Suissa S, Tardieu M for the KIDSEP Study Group. Clinically observed chickenpox and the risk of childhood-onset multiple sclerosis. Am. J. Epidemiol.169, 1260–1266 (2009).
   PubMed Web of Science ®Google Scholar
• Sriram S, Stratton CW, Yao S et al.Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann. Neurol.46, 6–14 (1999).
   PubMed Web of Science ®Google Scholar
• Layh-Schmitt G, Bendl C, Hildt U et al. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann. Neurol.47, 652–655 (2000).
   PubMed Web of Science ®Google Scholar
• Gieffers J, Pohl D, Treib J et al. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis. Ann. Neurol.49, 585–589 (2001).
   PubMed Web of Science ®Google Scholar
• Boman J, Roblin PM, Sundström P, Sandström M, Hammerschlag MR. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology54, 265 (2000).
   PubMed Web of Science ®Google Scholar
• Treib J, Haass A, Stille W et al. Multiple sclerosis and Chlamydia pneumoniae. Ann. Neurol.47, 408 (2000).
   PubMed Web of Science ®Google Scholar
• Bagos PG, Nikolopoulos G, Ioannidis A. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult. Scler.12, 397–411 (2006).
   PubMed Web of Science ®Google Scholar
• Kaufman M, Gaydos CA, Sriram S, Boman J, Tondella ML, Norton HJ. Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results. Mult. Scler.8, 289–294 (2002).
   PubMed Web of Science ®Google Scholar
• Karvonen M, Tuomilehto J, Pitkäniemi J, Naukkarinen A, Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int. J. Epidemiol.23, 1315–1321 (1994).
   PubMed Web of Science ®Google Scholar
• Contini C, Cultrera R, Seraceni S, Castellazzi M, Granieri E, Fainardi E. Cerebrospinal fluid-molecular demonstration of Clamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing–remitting multiple sclerosis. Mult. Scler.10, 360–369 (2004).
   PubMed Web of Science ®Google Scholar
• Munger KL, Peeling RW, Hernán MA et al. Infection with Chlamydia pneumoniaeand risk of multiple sclerosis. Epidemiology14, 141–147 (2003).
   PubMed Web of Science ®Google Scholar
• Munger KL, DeLorenzo GN, Levin LI et al. A prospctive study of Chlamydia pneumoniaeinfection and rik of MS in two US cohorts. Neurology62, 1799–1803 (2004).
   PubMed Web of Science ®Google Scholar
• Derfuss D, Gurkov R, Then Berg F et al. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain124, 1325–1335 (2001).
   PubMed Web of Science ®Google Scholar
• Lauer K. [Descriptive and analytical studies on the epidemiology of multiple sclerosis in the area of southern Hesse]. Thesis, Frankfurt, Germany (1993).
   Google Scholar
• Hernán MA, Zhang SM, Lipworth L, Olek MJ, Ascherio A. Multiple sclerosis and age at infection with common viruses. Epidemiology12, 301–306 (2001).
   PubMed Web of Science ®Google Scholar
• Bager P, Nielsen NM, Bihrmann K et al. Childhood infections and risk of multiple sclerosis. Brain127, 2491–2497 (2004).
   PubMed Web of Science ®Google Scholar
• Lauer K. Environmental associations with the risk of MS: the contribution of ecological studies. Acta Neurol. Scand. Suppl.161, 77–88 (1995).
   PubMedGoogle Scholar
• Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Neurol. Scand. Suppl.35(Suppl. 147), 132–147 (1960).
   Google Scholar
• Norman JE, Kurtzke JF, Beebe GW. Epidemiology of multiple sclerosis in U.S. veterans. 2. Latitude, climate, and the risk of multiple sclerosis. J. Chronic Dis.136, 551–559 (1983).
   Google Scholar
• Sutherland JM, Tyrer JH, Eadie MJ. The prevalence of multiple sclerosis in Australia. Brain85, 149–164 (1962).
   PubMed Web of Science ®Google Scholar
• van der Mei IAF, Ponsonby AL, Blizzard L, Dwyer T. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology20, 168–174 (2001).
   PubMed Web of Science ®Google Scholar
• Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol.7, 268–277 (2008).
   PubMed Web of Science ®Google Scholar
• Georgi F, Hall P. Studies on multiple sclerosis frequency in Switzerland and East Africa. Acta Neurol. Scand. Suppl.35(Suppl. 147), 75–84 (1960).
   Google Scholar
• Freedman DM, Dosemeci M, Alavanja MCR. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case–control study based on death certificates. Occup. Environ. Med.57, 418–421 (2000).
   PubMed Web of Science ®Google Scholar
• Goldacre MJ, Seagroatt V, Yeates D, Acheson ED. Skin cancer in people with multiple sclerosis: a record linkage study. J. Epidemiol. Community Health58, 142–144 (2004).
   PubMed Web of Science ®Google Scholar
• Cendrowski W, Wender M, Dominik W, Flejsierowicz Z, Owsianowski M, Popiel M. Epidemiological study of multiple sclerosis in Western Poland. Eur. Neurol.2, 90–108 (1969).
   PubMed Web of Science ®Google Scholar
• Antonovsky A, Leibowitz U, Smith HA et al. Epidemiologic study of multiple sclerosis in Israel. I. An overall review of methods and findings. Arch. Neurol.13, 183–193 (1965).
   PubMedGoogle Scholar
• van der Mei IAF, Ponsonby A-L, Dwyer T et al. Past expopsure to sun, skin phenotype, and risk of multiple sclerosis: case–control study. Br. Med. J.327, 316–320 (2003).
   PubMed Web of Science ®Google Scholar
• Kampman MT, Wilsgaard F, Mellgren SI. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J. Neurol.254, 471–477 (2007).
   PubMed Web of Science ®Google Scholar
• Islam T, Gauderman WJ, Cozen W, Mack TM. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology69, 381–388 (2007).
   PubMed Web of Science ®Google Scholar
• Duthie MS, Kinber I, Norval M. The effects of ultraviolet radiation on the immune system. Br. J. Dermatol.140, 995–1009 (1999).
   PubMed Web of Science ®Google Scholar
• Constantinescu CS. Melanin, melatonin, melanocyte-stimulating hormone, and the susceptibility to autoimmune demyelination: a rationale for light therapy in multiple sclerosis. Med. Hypotheses45, 455–458 (1995).
   PubMed Web of Science ®Google Scholar
• Goldberg P. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part 1: Sunlight, dietary factors and epidemiology. Int. J. Environ. Stud.6, 19–27 (1974).
   Web of Science ®Google Scholar
• Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology44, 1687–1692 (1994).
   PubMed Web of Science ®Google Scholar
• Ozgogmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J. Bone Miner. Metab.23, 309–313 (2005).
   PubMed Web of Science ®Google Scholar
• Soilu-Hanninen M, Airas L, Mononen I, Heikkila A, Viljanen M, Hanninen A. 25-hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult. Scler.11, 266–271 (2005).
   PubMed Web of Science ®Google Scholar
• Soilu-Hanninen M, Laaksonen M, Laitinen I, Eralinna JP, Lilius EM, Mononen I. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry79, 152–157 (2008).
   PubMed Web of Science ®Google Scholar
• Barnes MS, Bonham MP, Robson PJ et al. Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers. Mult. Scler.13, 670–672 (2007).
   PubMed Web of Science ®Google Scholar
• van der Mei IA, Ponsonby AL, Dwyer T et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J. Neurol.254, 581–590 (2007).
   PubMed Web of Science ®Google Scholar
• Kragt JJ, van Amerongen BM, Killestein J et al. Higher level of 25-hyroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult. Scler.15, 9–15 (2009).
   PubMed Web of Science ®Google Scholar
• Orton SM, Morris AP, Herrera BM et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am. J. Clin. Nutr.88, 441–447 (2008).
   PubMed Web of Science ®Google Scholar
• Munger KL, Zhang SM, O’Reilly E et al. Vitamin D intake and incidence of multiple sclerosis. Neurology62, 60–65 (2004).
   PubMed Web of Science ®Google Scholar
• Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA296, 2832–2838 (2006).
   PubMed Web of Science ®Google Scholar
• Hayes CE, Cantorna MT, Deluca HF. Vitamin D and multiple sclerosis. Proc. Soc. Exp. Biol. Med.216, 21–27 (1997).
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med.229, 1136–1142 (2004).
   PubMed Web of Science ®Google Scholar
• Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis. J. Neuroimmunol.194, 7–17 (2008).
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Hayes CE, De Luca HF. 1,25-dihydroxyvitamin D3 reversibly blocks the progressioon of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl Acad. Sci. USA93, 7861–7864 (1996).
   PubMed Web of Science ®Google Scholar
• Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell. Mol. Biol. (Noisy-le-Grand)49, 277–300 (2003).
   PubMed Web of Science ®Google Scholar
• Rao M, Goswami R, Gupta N, Ray D, Tandon N, Kumar N. Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphism in Asian Indians. Am. J. Clin. Nutr.83, 1411–1419 (2006).
   PubMed Web of Science ®Google Scholar
• Goswami R, Mishra SK, Kochupillai N. Prevalence and potential significance of vitamin D deficiency in Asian Indians. Indian J. Med. Res.127, 229–238 (2008).
   PubMed Web of Science ®Google Scholar
• Goswami R, Marwaha RK, Gupta N et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br. J. Nutr.102, 382–386 (2009).
   PubMed Web of Science ®Google Scholar
• Bharucha NE. Bharucha EP, Wadia NH et al. Prevalence of multiple sclerosis in the Parsis of Bombay. Neurology38, 727–729 (1988).
   PubMed Web of Science ®Google Scholar
• Singhal BS. Multiple sclerosis and related demyelinating disorders in Indian context. Neurol. India35, 1–12 (1987).
   Google Scholar
• Gourie-Devi M, Gururaj G, Satishchandra P, Subbakrishna DK. Prevalence of neurological disorders in Bangalore, India: a community-based study with a comparison between urban and rural areas. Neuroepidemiology23, 261–268 (2004).
   PubMed Web of Science ®Google Scholar
• Brustad M, Randanger T, Wilsgaard T, Aksnes L, Lund E. Change in plasma levels of vitamin D after consumption of cod-liver and fresh cod-liver oil as part of the traditional north Norwegian fish dish ‘Mølje’. Int. J. Circumpolar Health62, 40–53 (2003).
   PubMedGoogle Scholar
• Kurtzke JF. Epidemiology and etiology of multiple sclerosis. Phys. Med. Rehabil. Clin. N. Am.16, 327–349 (2005).
   PubMedGoogle Scholar
• Oliveri B, Plantalech L, Wittich AC et al. High prevalence of vitamin D insufficiency in healthy elderly people living at home in Argentina. Eur. J. Clin. Nutr.58, 337–342 (2004).
   PubMed Web of Science ®Google Scholar
• Melcon MO, Gold L, Carrá C et al. Argentine Patagonia: prevalence and clinical features of multiple sclerosis. Mult. Scler.14, 656–662 (2008).
   PubMed Web of Science ®Google Scholar
• Ghadirian P, Dadgostar B, Azani R, Maisonneuve P. A case–control study of the association between socio-demographic, lifestyle and medical hisatory factors and multiple sclerosis. Can. J. Pubic Health92, 281–285 (2001).
   PubMed Web of Science ®Google Scholar
• Riise T, Nortvedt MW, Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology61, 1122–1124 (2003).
   PubMed Web of Science ®Google Scholar
• Pekmezovic T, Drulovic J, Milenkovic M et al. Lifestyle factors and multiple sclerosis: a case–control study in Belgrade. Neuroepidemiology27, 212–216 (2006).
   PubMed Web of Science ®Google Scholar
• Hedström AK, Bäärnhjelm M, Olsson T, Alfredsson L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology73, 696–701 (2009)
   PubMed Web of Science ®Google Scholar
• Sundström P, Nyström P, Hallmans G. Smoke exposure increases the risk for multiple sclerosis. Eur. J. Neurol.15, 579–583 (2008).
   PubMed Web of Science ®Google Scholar
• Hernan MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain128, 1461–1465 (2005).
   PubMed Web of Science ®Google Scholar
• Hernán MA, Olek MJ, Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am. J. Epidemiol.154, 69–74 (2001).
   PubMed Web of Science ®Google Scholar
• Villard-Mackintosh L, Vessey MP. Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception47, 161–168 (1993).
   PubMed Web of Science ®Google Scholar
• Casetta I, Granieri E, Malagu S et al. Environmental risk factors and multiple sclerosis: A community-based study in the province of Ferrara, Italy. Neuroepidemiology13, 120–128 (1994).
   PubMed Web of Science ®Google Scholar
• Thorogood M, Hannaford PC. The influence of oral contraceptives on the risk of multiple sclerosis. Br. J. Obstet. Gynaecol.105, 1296–1299 (1998).
   PubMedGoogle Scholar
• Hawkes CH. Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult. Scler.13, 610–615 (2007).
   PubMed Web of Science ®Google Scholar
• Mikaeloff Y, Caridade G, Tardieu M, Suissa S for the KIDSEP study group. Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain130, 2589–2595 (2007).
   PubMed Web of Science ®Google Scholar
• Montgomery SM, Bahmanyar S, Hillert J, Ekbom A, Olsson T. Maternal smoking during pregnancy and multiple sclerosis amongst offspring. Eur. J. Neurol.15, 1395–1399 (2008).
   PubMed Web of Science ®Google Scholar
• Koch M, van Harten A, Uyttenboogaart M, De Keyser J. Cigarette smoking and progression in multiple sclerosis. Neurology69, 1515–1520 (2007).
   PubMed Web of Science ®Google Scholar
• Di Pauli F, Reindl F, Ehling R et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult. Scler.14, 1026–1030 (2008).
   PubMed Web of Science ®Google Scholar
• Sundstöm P, Nyström L. Smoking worsens the prognosis in multiple sclerosis. Mult. Scler.14, 1031–1035 (2008).
   PubMed Web of Science ®Google Scholar
• Pittas F, Ponsonby A-L, van der Mei I et al. Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J. Neurol.256, 577–585 (2009).
   PubMed Web of Science ®Google Scholar
• Zivadinov R, Weinstock-Guttman B, Hashimi K et al. Smoking is associated with increased lesion volume and brain atrophy in multiple sclerosis. Neurology73, 504–510 (2009).
   PubMed Web of Science ®Google Scholar
• Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J. Neuroimmunol.83, 148–156 (1998).
   PubMed Web of Science ®Google Scholar
• McCoy EC, Rosenkranz HS. Cigarette smoking may yield nitroarenes. Cancer Lett.15, 9–13 (1982).
   PubMed Web of Science ®Google Scholar
• Schlemitz S, Pfannhauser W. Analysis of nitro-PAHs in food matrices by on-line reduction and high performance liquid chromatography. Food Addit. Contam.13, 969–977 (1996).
   PubMedGoogle Scholar
• Schlemitz S, Pfannhauser W. Monitoring of nitropolycyclic aromatic hydrocarbons in food using gas chromatography. Z. Lebensm. Unters. Forsch.203, 61–64 (1996).
   PubMedGoogle Scholar
• Berr C, Puel J, Clanet M, Ruidavets JB, Mas JL, Aperovitch A. Risk factors in multipler sclerosis: a population-based case–control study in Hautes-Pyrénées, France. Acta Neurol. Scand.80, 46–50 (1989).
   PubMed Web of Science ®Google Scholar
• Spenceley M, Dick G. Breast-feeding and multiple sclerosis. Neuroepidemiology1, 216–222 (1982).
   Google Scholar
• Pisacane A, Impagliazzo N, Russo M et al. Breast feeding and multiple sclerosis. Br. Med. J.308, 1411–1412 (1994).
   PubMed Web of Science ®Google Scholar
• Tarrats R, Ordoñez G, Rios C, Sotelo J. Varicella, ephermal breastfeeding and eczema as risk factors for multiple sclerosis in Mexicans. Acta Neurol. Scand.105, 88–94 (2002).
   PubMed Web of Science ®Google Scholar
• Jackson KM, Nazar AM. Breastfeeding, the immune response, and long-term health. J. Am. Osteopath. Assoc.106, 203–207 (2006).
   PubMedGoogle Scholar
• Knip M, Akerblom HK. Early nutrition and later diabetes risk. Adv. Exp. Med. Biol.569, 142–150 (2005).
   PubMed Web of Science ®Google Scholar
• Liao KP, Alfredsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr. Op. Rheumatol.21, 279–283 (2009).
   PubMed Web of Science ®Google Scholar
• Rosenberg KD, McMurtrie C, Kerker BD, Na Y, Graham EH. Breast-feeding initiation in New York city, 1979–1996. Am. J. Public Health88, 1850–1852 (1998).
   Google Scholar
• Langer-Gould A, Huang SM, Leimpeter AD, Albers KB, van den Eeden SK, Nelson LM. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch. Neurol.66, 958–963 (2009).
   PubMed Web of Science ®Google Scholar
• Seyfert S, Klapps P, Meisel C, Fischer T, Junghans C. Multiple sclerosis and other immunologic diseases. Acta Neurol. Scand.81, 37–42 (1990).
   PubMed Web of Science ®Google Scholar
• Kirby S, Brown MG, Murray TJ, Fisk JD, Stadnyk K, MacKinnon-Cameron D, Bhan V. Prevalence of other autoimmune diseases in patients with multiple sclerosis. Mult. Scler.11(Suppl. 1), 29 (2005).
   Google Scholar
• Gilani A, Robertson K, Lindzen E, Mann JD. Prevalence of comorbid autoimmune disease in a cohort of 66 multiple sclerosis ambulatory clinic patients. Neurology62(Suppl. 5), 224–225 (2004).
   Google Scholar
• Barcellos LF, Kamdar BD, Ramsay PP et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol.5, 924–931 (2006).
   PubMed Web of Science ®Google Scholar
• Nielsen N, Frisch M, Rostgaard K et al. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark. Mult. Scler.14, 823–829 (2008).
   PubMed Web of Science ®Google Scholar
• Pugliatti M, Sotgiu S, van Duijn CM, Rosati G. Recurrence of immuno-mediated disorders among relatives of multiple sclerosis patients in Sardinia. Mult. Scler.4, 370 (1998).
   Google Scholar
• Hemminki K, Li X, Sundquist J, Sundquist K. Familial risks for amyotrophic lateral sclerosis and autoimmune diseases. Neurogenetics10, 111–116 (2009).
   PubMed Web of Science ®Google Scholar
• Purrmann J, Arendt G, Cleveland S et al. Association of Crohn’s disease and multiple sclerosis. Is there a common background? J. Clin. Gastroenterol.14, 43–46 (1992).
   PubMed Web of Science ®Google Scholar
• Rang EH, Brooke BN, Hermon Taylor J. Association of ulcerative colitis with multiple sclerosis. Lancet2, 555 (1982).
   PubMed Web of Science ®Google Scholar
• Minuk GY, Lewkonia RM. Possible familial association of multiple sclerosis and inflammatory bowel disease. N. Engl. J. Med.314, 586 (1986).
   PubMed Web of Science ®Google Scholar
• Yacyshyn B, Meddings J, Sadowski D, Bowen-Yacyshyn MB. Multiple sclerosis patients have peripheral blood CD45R0 B cells and increased intestinal permeability. Dig. Dis. Sci.41, 2493–2498 (1996).
   PubMed Web of Science ®Google Scholar
• Geissler A, Anders T, Roth M et al. Focal white matter lesions in brain of patients with inflammatory bowel disease. Lancet345, 897–898 (1995).
   PubMed Web of Science ®Google Scholar
• Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology129, 819–826 (2005).
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Wadja A, Blachard JF. The clustering of other inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology129, 827–836 (2005).
   PubMed Web of Science ®Google Scholar
• Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ. Clustering of inflammatory bowel disease with immune mediated diseases among members of a Northern California-managed care organization. Am. J. Gastroenterol.102, 1–7 (2007).
   Web of Science ®Google Scholar
• Langer-Gould A, Albers KB, van den Eeden SK, Nelson LM. Comorbid autoimmune and allergic conditions in multiple sclerosis: a comprehensive population-based case–control study. Mult. Scler.14(Suppl.1), 188 (2008).
   PubMed Web of Science ®Google Scholar
• Wertmann E, Zilber N, Abramsky O. An association between multiple sclerosis and type I diabetes mellitus. J. Neurology239, 43–45 (1992).
   PubMed Web of Science ®Google Scholar
• Arpa J, Muñoz-Torrero J, Gonzáles J et al. Multiple sclerosis and type I diabetes mellitus. Eur. J. Neurol.3(Suppl. 5), 107 (1996).
   Google Scholar
• Milonas I, Bairaktaris C, Danilides M, Iakovidou E, Grigoriadis N, Tsounis S. Coexistence of multiple sclerosis and insulin-dependent diabetes mellitus (Type 1). Mult. Scler.3, 323 (1997).
   Google Scholar
• Cocco E, Sardu C, Lai M, Spinicci G, Contu P, Marrosu MG. Anticipation of age at onset in multiple sclerosis. A Sardinian cohort study. Neurology62, 1794–1798 (2004).
   PubMed Web of Science ®Google Scholar
• Marrosu M, Cocco E, Lai M, Spinicci G, Pischedda MP, Contu P. Patients with multiple sclerosis and risk of Type 1 diabetes mellitus in Sardinia, Italy: a cohort study. Lancet359, 1461–1465 (2001).
   Web of Science ®Google Scholar
• Russel MG, Stockbruegger RW. Epidemiology of inflammatory bowel disease: an update. Scand. J. Gastroenterol.31, 417–427 (1996).
   PubMed Web of Science ®Google Scholar
• Tragnone A, Valpiani D, Miglio F et al. Dietary habits as risk factors for inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol.7, 47–51 (1995).
   PubMed Web of Science ®Google Scholar
• Jowett SL, Seal CJ, Pearce MS et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut53, 1479–1484 (2004).
   PubMed Web of Science ®Google Scholar
• Lauer K. Inflammatory bowel disease: lessons from animal models. Am. J. Gastroenterol.103, 802 (2008).
   PubMed Web of Science ®Google Scholar
• Dahlquist GG. Viruses and other perinatal exposures as initiating events for β-cell destruction. Ann. Med.29, 413–417 (1997).
   PubMed Web of Science ®Google Scholar
• Dorman JS. Molecular epidemiology of insulin-dependent diabetes mellitus. Epidemiol. Rev.19, 91–98 (1997).
   PubMed Web of Science ®Google Scholar
• Dahlquist G. The aetiology of Type-1 diabetes: an epidemiological perspective. Acta Paediatr. Suppl.425, 5–10 (1998).
   PubMedGoogle Scholar
• Dahlquist GG, Blom LG, Persson L-Å, Sandström AIM, Wall SGI. Dietary factors and the risk of developing insulin dependent diabetes in childhood. Br. Med. J.300, 1302–1306 (1990).
   PubMed Web of Science ®Google Scholar
• Helgason T, Jonasson MR. Evidence for a food additive as cause of ketosis-prone diabetes. Lancet2, 716–720 (1981).
   PubMed Web of Science ®Google Scholar
• Helgasson T, Ewen SW, Ross IS, Stowers JM. Diabetes produced in mice by smoked/cured mutton. Lancet2, 1017–1022 (1982).
   PubMed Web of Science ®Google Scholar
• Virtanen SM, Jaakkola L, Räsänen L et al. Nitrate and nitrite intake and the risk for type-1 diabetes in Finnish children. Chidhood Diabetes in Finland Study Group. Diabetes Med.11, 656–662 (1994).
   PubMed Web of Science ®Google Scholar
• Palo J, Duchesne J, Wikström J. Malignant diseases among patients with multiple sclerosis. J. Neurol.216, 217–222 (1977).
   PubMed Web of Science ®Google Scholar
• Lebrun C, Debouverie M, Vermersch P et al. for le Club Francophone de la Sclérose en Plaque (CFSEP). Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis. Mult. Scler.14, 399–405 (2008).
   PubMed Web of Science ®Google Scholar
• Lauer K. [The risk of malignancy in multiple sclerosis patients in comparison with the general population: prospective data from a regional registry]. Gesundheitswesen57, 590 (1995).
   Google Scholar
• Materljan E, Materljan M, Materljan B, Vlačić H, Barićev-Novaković Z, Sepčic J. Multiple sclerosis and cancers in Croatia. A possible protective role of the ‘Mediterranean Diet’. Coll. Antropol.33, 539–545 (2009).
   PubMedGoogle Scholar
• Darmstaedter E. The mortality of multiple sclerosis 1975–1995 in the State of Lower Saxony, northern Germany. Mult. Scler.14, 189 (2008).
   Google Scholar
• Bellian KT, Devlin PM, Zimmer CA, Powell DM, Matticks CA, Edlich RF. Concurrence of multiple sclerosis and Hodgkin‘s disease. J. Emerg. Med.10, 13–18 (1992).
   PubMedGoogle Scholar
• Hjalgrim H, Rasmussen S, Rostgaard K et al. Familial clustering of Hodgkin lymphoma and multiple sclerosis. J. Natl Cancer Inst.96, 780–784 (2004).
   PubMedGoogle Scholar
• Vineis P, Crosignani P, Viganò C et al. Lymphomas and multiple sclerosis in a multicenter case–control study. Epidemiology12, 134–135 (2001).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Holford TR, Leasderer B et al. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in connecticut United States women. Cancer Causes Control15, 419–428 (2004).
   PubMed Web of Science ®Google Scholar
• Smedby KE, Vajdic CM, Falster M et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood111, 4029–4038 (2008).
   PubMed Web of Science ®Google Scholar
• Møller H, Kneller RW, Boice JD, Olsen JH. Cancer incidence following hospitalization for multiple sclerosis in Denmark. Acta Neurol. Scand.84, 214–220 (1991).
   PubMed Web of Science ®Google Scholar
• Nielsen NM, Rostgaard K, Rasmussen S et al. Cancer risk among patients with multiple sclerosis: a population-based register study. Int. J. Cancer118, 979–984 (2006).
   PubMed Web of Science ®Google Scholar
• Auwaerter PG. Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control? Expert Rev. Anti Infect. Ther.4, 1039–1049 (2006).
   PubMedGoogle Scholar
• Flavell KJ, Murray PG. Hodgkin’s disease and the Epstein–Barr virus. Mol. Pathol.53, 262–269 (2000).
   PubMedGoogle Scholar
• Wolfgram F. Similar geographical distribution of multiple sclerosis and cancer of the colon. Acta Neurol. Scand.52, 294–302 (1975).
   PubMed Web of Science ®Google Scholar
• Lauer K. The distribution of multiple sclerosis and 7 malignancies: a comparison in 12 regions. Schweiz. Arch. Neurol. Psychiatr.144, 348 (1993).
   Google Scholar
• Bahmanyar S, Montgomery SM, Hillert J, Ekbom A, Olsson T. Cancer risk among patients with multiple sclerosis and their patents. Neurology72, 1170–1177 (2009).
   PubMed Web of Science ®Google Scholar
• Langer-Gould A, Albers KB, Nelson LM, van den Eeden SK. Prevalence of vitamin D-, herpes-virus family and hormonally-related diseases in multiple sclerosis: a comprehensive population-based case–control study. Mult. Scler.14(Suppl. 1), 188 (2008).
   PubMed Web of Science ®Google Scholar
• Schuetz J, Waldemar G, Olsen JH, Johansen C. Risk for central nervous system disease among phone subscribers: a Danish retrospective cohort study. PloS One4(2), e4389 (2009).
   Google Scholar
• Feyching M, Jonsson F, Pedersen NL, Ahlbom A. Occupational magnetic field exposure and neurodegenerative disease. Epidemiology14, 413–419 (2003).
   PubMed Web of Science ®Google Scholar
• Johansen C, Koch-Henriksen N, Rasmussen S, Olsen JH. Multiple sclerosis among utility workers. Neurology52, 1279–1282 (1999).
   PubMed Web of Science ®Google Scholar
• Röösli M, Lörtscher M, Egger M et al. Mortality from neurodegenerative disease and exposure to extremely low-frequency magnetic fields: 31 years of observations on Swiss railway employees. Neuroepidemiology28, 197–206 (2007).
   PubMed Web of Science ®Google Scholar
• Huss A, Spoerri A, Egger M, Röösli M; for the Swiss National Cohort Study. Residence near power lines and mortality from neurodegenerative diseases: longitudinal study of the Swiss population. Am. J. Epidemiol.169, 167–175 (2009).
   PubMed Web of Science ®Google Scholar
• World Health Organization. Extremely Low Frequency Fields, Environmental Health Criteria 238. World Health Organization, Geneva, Switzerland (2007).
   Google Scholar
• Gregory AC, Shendell DG, Okosun IS, Gieseker KE. Multiple sclerosis disease distribution and potential impact of environmental air pollutants in Georgia. Sci. Total Environ.396, 42–51 (2008).
   PubMed Web of Science ®Google Scholar
• Oikonen M, Laaksonen M, Laippala P et al. Ambient air quality and occurrence of multiple sclerosis relapse. Neuroepidemiology22, 95–99 (2003).
   PubMed Web of Science ®Google Scholar
• Oikonen MK, Erälinna J-P. β-interferon protects multiple sclerosis patients against enhanced susceptibility to infections caused by poor air quality. Neuroepidemiology30, 13–19 (2008).
   PubMed Web of Science ®Google Scholar
• Ma JYC, Ma JKH. The dual effect of the particulate and organic components of diesel exhaust particles on the alteration of pulmonary immune/inflammatory responses and metabolic enzymes J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev.C20, 117–147 (2002).
   Google Scholar
• Barth SK, Kang HK, Bullman TA, Wallin MT. Neurological mortality among U.S. veterans of the Persian Gulf War: 13-year follow-up. Am. J. Ind. Med.52, 663–670 (2009).
   PubMed Web of Science ®Google Scholar
• Sanderson IR, Walker WA. Uptake and transportation of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology104, 622–639 (1993).
   PubMed Web of Science ®Google Scholar
• Alter M, Yamoor M, Harshe M. Multiple sclerosis and nutrition. Arch. Neurol.31, 267–272 (1974).
   PubMedGoogle Scholar
• Knox EG. Foods and diseases. Br. J. Prev. Soc. Med.31, 71–80 (1977).
   PubMedGoogle Scholar
• Swank R, Lerstad O, Strøm A, Backer J. Multiple sclerosis in rural Norway. Its geographic and occupational incidence in relation to nutrition. N. Engl. J. Med.246, 721–728 (1952).
   PubMed Web of Science ®Google Scholar
• Lauer K. Nutrition and multiple sclerosis. Mult. Scler.12(Suppl. 1), 133 (2006).
   PubMed Web of Science ®Google Scholar
• Nanji AA, Narod S. Multiple sclerosis, latitude and dietary fat: is pork the missing link? Med. Hypotheses20, 279–282 (1986).
   PubMed Web of Science ®Google Scholar
• Lauer K. Dietary changes in temporal relation to multiple sclerosis in the Faroe Islands. An evaluation of literary sources. Neuroepidemiology8, 200–206 (1989).
   PubMed Web of Science ®Google Scholar
• Lauer K. Multiple sclerosis in relation to meat preservation in France and Switzerland. Neuroepidemiology8, 308–315 (1989).
   PubMed Web of Science ®Google Scholar
• Lauer K. The Fennoscandian focus of multiple sclerosis and dietary exposures: an ecological comparison. L’Arcispedale S.Anna di Ferrara46(Suppl.), 17–18 (1996).
   Google Scholar
• Lauer K. Sausage preservation methods and the prevalence of multiple sclerosis: an ecological study. Ecol. Food Nutr.46, 1–11 (2007).
   Web of Science ®Google Scholar
• Gusev E, Boiko A, Lauer K, Riise T, Deomina T. Environmental risk factors in MS: a case–control study in Moscow. Acta Neurol. Scand.94, 386–394 (1996).
   PubMed Web of Science ®Google Scholar
• Zorzon M, Zivadinov R, Nasuelli D et al. Risk factors of multiple sclerosis: a case–control study. Neurol. Sci.24, 242–247 (2003).
   PubMed Web of Science ®Google Scholar
• Sepcic J, Mesaros E, Materljan E, Sepic-Grahovac D. Nutritional factors and multiple sclerosis in Gorski Kotar, Croatia. Neuroepidemiology12, 234–240 (1993).
   PubMed Web of Science ®Google Scholar
• Ghadirian P, Jain M, Ducic S, Shatenstein B, Morriset R. Nutritional factors in the aetiology of multiple sclerosis: a case–control study in Montreal, Canada. Int. J. Epidemiol.27, 845–852 (1998).
   PubMed Web of Science ®Google Scholar
• Smirnova NF, Boiko AN, Deomina TL, Gusev EI. Smoked meat is the main environmental risk factor in Moscow population: data of a new case–control study. Mult. Scler.3, 285 (1997).
   Google Scholar
• Lauer K, Geilenkeuser M, Wahl A, Firnhaber W, Claus D. The intake of selected foods in multiple sclerosis: a possible interaction with late childhood infections. Mult. Scler.14(Suppl. 1), 189 (2008).
   Google Scholar
• Zhang SM, Willett WC, Hernán MA, Olek MJ, Ascherio A. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am. J. Epidemiol.152, 1056–1064 (2000).
   PubMed Web of Science ®Google Scholar
• Pugliatti M, Casetta I, Cossu P et al. An international case–control study of risk factors for multiple sclerosis. Mult. Scler.140(Suppl. 1), 197 (2008).
   Google Scholar
• Lauer K. A possible paradox in the immunology of multiple sclerosis: its apparent lack of ‘specificity’ might provide clues to the etiology. Med. Hypotheses40, 368–374 (1993).
   PubMed Web of Science ®Google Scholar
• Knowles ME, Gilbert J, McWeeny DJ. Phenols in smoked, cured meats: nitrosation of phenols in liquid smokes and smoked bacon. J. Sci. Food Agr.26, 267–276 (1975).
   PubMed Web of Science ®Google Scholar
• Chen LB, Issenberg P. Interactions of some wood smoke components with e aminogroups in proteins. J. Agric. Food Chem.20, 1113–1115 (1972).
   Web of Science ®Google Scholar
• Achtnich M, Zoeller M. Autoreactive ntibodies in thymus and spleen of neonatal and young adult BALB/c mice: influence of prenatal tolerization. Scand. J. Immunol.33, 25–36 (1991).
   PubMed Web of Science ®Google Scholar
• Weltzien HU, Moulon C, Martin S, Padovan E, Hartmann U, Kohler J. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology107, 141–151 (1996).
   PubMed Web of Science ®Google Scholar
• Lauer K. The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytical study. J. Clin. Epidemiol.47, 43–48 (1994).
   PubMed Web of Science ®Google Scholar
• Bates D, Cartlidge NE, French JM et al. A double-blind controlled trial of long-chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry52, 18–22 (1989).
   PubMed Web of Science ®Google Scholar
• Kampman MT, Brustad M. Vitamin D: a candidate for the environmental effect in multiple sclerosis. Observations from Norway. Neuroepidemiology30, 140–146 (2008).
   PubMed Web of Science ®Google Scholar
• Achiron A, Barak Y, Shmuel M, Izhak Y, Faibel M, Edelstein S. Alfacalcidol treatment in multiple sclerosis. Clin. Neurophamacol.26, 53 (2003).
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Lesaux J, Rice GPA, Kremenchutzky M, Ebers GC. A pilot study of oral calcitriol (1,25-dihydroxyvitramin D3) for relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry76, 1294–1296 (2005).
   PubMed Web of Science ®Google Scholar
• Darmstaedter E, Firnhaber W, Lauer K. Food consumption in Lower Saxony, northern Germany, in relation to the multiple sclerosis mortality 1975–1995: an ecological study. Presented at Conference of German Society of Epidemiology, Muenster, Germany, September 16–19 (2009).
   Google Scholar
• Wender M, Kazmierski R. The descriptive and analytical epidemiology of multiple sclerosis in Western Poland. In: Multiple Sclerosis in Europe. An Epidemiological Update. Firnhaber W, Lauer K (Eds). LTV Press, Germany, 241–248 (1994).
   Google Scholar
• Zhang SM, Hernán MA, Olek MJ, Spiegelman D, Willet WC, Ascherio A. Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women. Neurology57, 75–80 (2001).
   PubMed Web of Science ®Google Scholar
• Fitzgerald G, Harbige LS, Forti A, Crawford MA. The effect of nutritional counselling on diet and plasma EFA status in multiple sclerosis patiens over 3 years. Hum. Nutr. Appl. Nutr.41A, 297–310 (1987).
   Google Scholar
• World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. AICR, DC, USA (2000).
   Google Scholar
• Kleinbaum DG, Klein M. Logistic Regression. A Self-learning Text. Springer, NY, USA (2002).
   Google Scholar
• De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. Integrating risk factors. HLA-DRB1*1501 and Epstein–Barr virus in multiple sclerosis. Neurology70, 1113–1118 (2008).
   PubMed Web of Science ®Google Scholar
• Cocco E, Sardu C, Murru R et al. Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population. Mult. Scler.15, 1030–1036 (2009).
   PubMed Web of Science ®Google Scholar
• Sundström P, Nyström M, Ruuth K, Lundgren E. Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis. J. Neuroimmunol.215, 102–107 (2009).
   PubMed Web of Science ®Google Scholar
• Martínez A, Álvarez-Lafuente R, Mas A et al. Environment–gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA. Hum. Immunol.68, 695–689 (2007).
   Google Scholar
• Dickinson JL, Perera DI, van der Mei AF et al. Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult. Scler.15, 563–570 (2009).
   PubMed Web of Science ®Google Scholar
• Marrie RA. When one and one make three. HLA and EBV infection in MS. Neurology70, 1067–1068 (2008).
   PubMed Web of Science ®Google Scholar
• Simon KC, van der Mei I, Munger KL et al. Smoking as an independent risk factor for multiple sclerosis: considering possible combined effects with the human leucocyte antigen DR15 genotype and anti-EBNA antibody titers. Mult. Scler.14(Suppl. 1), 200 (2008).
   Google Scholar
• Lukes RJ, Cox FH. Clinical and morphological findings in 30 fatal cases of infectious mononucleosis. Am. J. Pathol.34, 586 (1958).
   Google Scholar
• Sheehy TW, Artenstein MS, Green RW. Small intestinal mucosa in certain viral diseases. JAMA190, 1023–1028 (1964).
   PubMed Web of Science ®Google Scholar
• Lucas RM, Ponsonby A-L, McMichael AJ et al. Observational analytical studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function. Mult. Scler.13, 827–839 (2007).
   PubMed Web of Science ®Google Scholar
• Greenberg B, Goins J, Frohman E et al. Establishment of a large scale, multidisciplinary sample and data repository for determining genetic and environmental causes of multiple sclerosis. Mult. Scler.13, S93 (2007).
   Google Scholar
• Flachenecker P, Stuke K. National MS registries. J. Neurol.255(Suppl. 6), 102–108 (2008).
   PubMed Web of Science ®Google Scholar
• Lauer K. Divergent risk of multiple sclerosis in two anabaptist communities in America. Med. Hypotheses67, 969–974 (2006).
   PubMed Web of Science ®Google Scholar
• Lauer K. Multiple sclerosis frequency in Israel’s diverse populations. Neurology68, 311 (2007).
   PubMed Web of Science ®Google Scholar
• Lauer K. The association of the multiple sclerosis mortality 1965–1994 in Canada with food retail trade and food-related occupations: an ecological study. Neuroepidemiology33, 198 (2009).
   Google Scholar
• Lauer K. Food consumption in northern and southern States of the USA: an ecological study on the risk of multiple sclerosis in space and time. Mult. Scler.15(Suppl. 2), 44 (2009).
   Google Scholar